Related Experiment Videos
[Periarteritis nodosa induced by hepatitis B virus]
1Service de Médecine Interne, Hôpital Avicenne, Bobigny, France.
Pathologie-Biologie
|April 24, 1999
Summary
Hepatitis B virus-related polyarteritis nodosa (HBV-PAN) is a rare, acute condition. Management involves steroids, plasma exchange, and antivirals, with an 80% ten-year disease-free survival rate.
Area of Science:
- Immunology
- Infectious Diseases
- Rheumatology
Context:
- Hepatitis B virus (HBV) infection can trigger Polyarteritis Nodosa (PAN), a rare vasculitis.
- The incidence of HBV-related PAN has significantly declined in the past decade.
- HBV-PAN presents acutely within six months of HBV infection.
Purpose:
- To describe the clinical features, diagnosis, and management of HBV-related PAN.
- To highlight key differences between HBV-related PAN and classic PAN.
- To report on the prognosis and serological outcomes of patients with HBV-PAN.
Summary:
- HBV-related PAN shares features with classic PAN but commonly presents with abdominal signs, renal failure, malignant hypertension, and orchitis.
- Antineutrophil cytoplasmic antibody tests are typically negative in HBV-related PAN.
- Treatment includes a short course of steroids, plasma exchange, and antiviral medications.
- The ten-year disease-free survival rate is approximately 80%.
Impact:
- Understanding HBV-PAN aids in timely diagnosis and appropriate management of this rare condition.
- The declining incidence underscores the impact of HBV vaccination and antiviral therapies.
- Prognostic data informs patient counseling and long-term follow-up strategies.